✦ LIBER ✦

Toxicity and antitumor activity of 5-fluorouracil in combination with leucovorin. Role of dose schedule and route of administration of leucovorin

✍ Scribed by Youcef M. Rustum

Publisher: John Wiley and Sons
Year: 1989
Tongue: English
Weight: 440 KB
Volume: 63
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(19890315)63:6+<1013::aid-cncr2820631304>3.0.co;2-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Elimination of dose limiting toxicities

Elimination of dose limiting toxicities of cisplatin, 5-fluorouracil, and leucovorin using a weekly 24-hour infusion schedule for the treatment of patients with nasopharyngeal carcinoma

✍ Lewis R. Schwarz 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB 👁 2 views

Efficacy of high-dose oral leucovorin an

Efficacy of high-dose oral leucovorin and 5-fluorouracil in advanced colorectal carcinoma. Plasma and tissue pharmacokinetics

✍ John D. Hines; David J. Adelstein; Jeffrey L. Spiess; Paul Giroski; Susan Gear C 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 457 KB 👁 2 views

A comprehensive review of 5-fluorouracil

A comprehensive review of 5-fluorouracil and leucovorin in patients with metastatic colorectal carcinoma

✍ David Machover 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

## Background: Colorectal carcinoma is the third leading cause of cancer-related death. the primary treatment for patients with metastatic colorectal carcinoma is systemic chemotherapy with 5-fluorouracil (5-fu) and leucovorin (lv), a biomodulator of 5-fu that has been shown to enhance its activity

Phase II trials of 5-fluorouracil and le

Phase II trials of 5-fluorouracil and leucovorin in patients with metastatic gastric or pancreatic carcinoma

✍ Joseph Rubin; James G. Gallagher; Georgene Schroeder; Allan J. Schutt; Robert J. 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 384 KB 👁 2 views

Conducted as a collaborative trial of North Central Cancer Treatment Group and Mayo Clinic.

Phase II study of oral eniluracil, 5-flu

Phase II study of oral eniluracil, 5-fluorouracil, and leucovorin in patients with advanced colorectal carcinoma

✍ Neal J. Meropol; Donna Niedzwiecki; Donna Hollis; Richard L. Schilsky; Robert J. 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 2 views

Pre-clinical evaluation of the Gastrimmu

Pre-clinical evaluation of the Gastrimmune immunogen alone and in combination with 5-fluorouracil/leucovorin in a rat colorectal cancer model

✍ Susan A. Watson; Dov Michael; Timothy A. Justin; Stephen Grimes; Teresa M. Morri 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 French ⚖ 135 KB 👁 2 views

Mature and post-translational precursor gastrin forms are growth factors for colorectal tumours. The immunogen Gastrimmune is composed of the amino terminus of gastrin-17 linked to diphtheria toxoid and raises antibodies in situ which neutralise amidated and glycine-extended gastrin-17. The aim of t